The FDA banned Red Dye No. 3. The additive is found in over 9,000 U.S. products. Here’s how to avoid it, and what to reach ...

Zentalis Pharmaceuticals said it would cut 40% of its workforce as part of a restructuring to support the late-stage development of its cancer-drug azenosertib.

In a harsh letter to lawmakers considering Robert F. Kennedy Jr.’s nomination for health secretary, Ms. Kennedy called her ...

That’s because Trump’s nominee to lead the Department of Health and Human Services is Robert F. Kennedy Jr., who is an anti-science, anti-vaccine whack job who has promoted the unsafe consumption of ...

Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...

Fred Hutch news release clinical trial shows fecal microbiota transplantation helped with gut microbiome recovery in patients after stem cell transplantation ...

ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ...

During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...